Oliver Freudenreich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Oliver Freudenreich has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
Donald C. Goff
Massachusetts General Hospital
9 shared publicationsDavid C. Henderson
Massachusetts General Hospital
5 shared publications- David C. Henderson
Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA
4 shared publications - Donald C. Goff
The Schizophrenia Program, Massachusetts General Hospital and Harvard Medical School, USA
4 shared publications - Jared P. Walsh
Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA, rutgers.edu
4 shared publications - Xiaoduo Fan
Psychotic Disorders Program, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, United States
4 shared publications
Latest Publications
- 1 September 2015
- Published by Elsevier in Psychosomatics
- Vol. 56 (5) , 445-459
Updates in Psychosomatic Medicine: 2014
- 1 September 2015
- Published by Elsevier in Psychosomatics
- Vol. 56 (5) , 445-459
Updates in Psychosomatic Medicine: 2014
- 3 May 2013
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 128 (4) , 322
Horror diagnosticus psychiatricus - the fear of expanding nosologies and overdiagnosis in psychiatry
- 3 May 2013
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 128 (4) , 322
Horror diagnosticus psychiatricus - the fear of expanding nosologies and overdiagnosis in psychiatry
- 1 January 2013
- Published by Springer Nature in Academic Psychiatry
- Vol. 37 (1) , 27-30
Training in a Clozapine Clinic for Psychiatry Residents: A Plea and Suggestions for Implementation
The authors sought to develop a model educational clinic and curriculum for psychiatric residents, to increase knowledge and comfort about clozapine prescribing. This matters because clozapine is an important evidence-based treatment for refractory schizophrenia that remains underutilized in clinical practice. This is a description of how the Clozapine Clinic of the Massachusetts General Hospital (MGH) Schizophrenia Program was integrated into the curriculum of the MGH-McLean Adult Psychiatric Residency. PGY-II residents participated in a weekly clozapine clinic with direct patient contact and accompanying curriculum-based instruction for a 6-week period. The method of teaching by participating in a dedicated Clozapine Clinic received favorable feedback. Residents’ knowledge about clozapine increased. Residency programs should determine whether their trainees receive sufficient training in the use of clozapine and consider setting up clozapine clinics where feasible.
- 1 January 2013
- Published by Springer Nature in Academic Psychiatry
- Vol. 37 (1) , 27-30
Training in a Clozapine Clinic for Psychiatry Residents: A Plea and Suggestions for Implementation
The authors sought to develop a model educational clinic and curriculum for psychiatric residents, to increase knowledge and comfort about clozapine prescribing. This matters because clozapine is an important evidence-based treatment for refractory schizophrenia that remains underutilized in clinical practice. This is a description of how the Clozapine Clinic of the Massachusetts General Hospital (MGH) Schizophrenia Program was integrated into the curriculum of the MGH-McLean Adult Psychiatric Residency. PGY-II residents participated in a weekly clozapine clinic with direct patient contact and accompanying curriculum-based instruction for a 6-week period. The method of teaching by participating in a dedicated Clozapine Clinic received favorable feedback. Residents’ knowledge about clozapine increased. Residency programs should determine whether their trainees receive sufficient training in the use of clozapine and consider setting up clozapine clinics where feasible.
- 1 September 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 140 (1-3) , 260-261
Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia
- 1 September 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 140 (1-3) , 260-261
Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia
- 19 April 2012
- Published by Wolters Kluwer Health in Harvard Review of Psychiatry
- Vol. 20 (2) , 79-85
Psychiatric Polypharmacy: A Clinical Approach Based on Etiology and Differential Diagnosis
Polypharmacy is common clinical practice in the United States for many psychiatric conditions and for many reasons. In this article we encourage clinicians to use the familiar practice of differential diagnosis to systematically identify etiological factors contributing to polypharmacy. We offer a clinical approach based on (1) reviewing the four main factors responsible for polypharmacy (the disease, the patient, the physician, and society) and (2) answering two questions about optimizing medication regimens (What can I do without explicit permission from the patient or others? What can I do with permission from them?). We contend that all physicians share a professional responsibility for prescribing medications judiciously because unnecessary prescribing exposes patients to unwarranted risks and squanders valuable and scarce resources. Psychiatrists can ask themselves a Kantian question: would my way of prescribing lead to good, socially acceptable outcomes if followed by all physicians treating similar patients?
- 19 April 2012
- Published by Wolters Kluwer Health in Harvard Review of Psychiatry
- Vol. 20 (2) , 79-85
Psychiatric Polypharmacy: A Clinical Approach Based on Etiology and Differential Diagnosis
Polypharmacy is common clinical practice in the United States for many psychiatric conditions and for many reasons. In this article we encourage clinicians to use the familiar practice of differential diagnosis to systematically identify etiological factors contributing to polypharmacy. We offer a clinical approach based on (1) reviewing the four main factors responsible for polypharmacy (the disease, the patient, the physician, and society) and (2) answering two questions about optimizing medication regimens (What can I do without explicit permission from the patient or others? What can I do with permission from them?). We contend that all physicians share a professional responsibility for prescribing medications judiciously because unnecessary prescribing exposes patients to unwarranted risks and squanders valuable and scarce resources. Psychiatrists can ask themselves a Kantian question: would my way of prescribing lead to good, socially acceptable outcomes if followed by all physicians treating similar patients?
- 1 March 2012
- Published by Springer Nature in Academic Psychiatry
- Vol. 36 (2)
Impact of a Metabolic Screening Bundle on Rates of Screening for Metabolic Syndrome in a Psychiatry Resident Outpatient Clinic
Although it is widely acknowledged that second-generation antipsychotics are associated with cardiometabolic side effects, rates of metabolic screening have remained low. The authors created a quality-improvement (QI) intervention in an academic medical center outpatient psychiatry resident clinic with the aim of improving rates of screening for metabolic syndrome in patients being prescribed antipsychotic medications.
- 1 March 2012
- Published by Springer Nature in Academic Psychiatry
- Vol. 36 (2)
Impact of a Metabolic Screening Bundle on Rates of Screening for Metabolic Syndrome in a Psychiatry Resident Outpatient Clinic
Although it is widely acknowledged that second-generation antipsychotics are associated with cardiometabolic side effects, rates of metabolic screening have remained low. The authors created a quality-improvement (QI) intervention in an academic medical center outpatient psychiatry resident clinic with the aim of improving rates of screening for metabolic syndrome in patients being prescribed antipsychotic medications.
- 1 January 2012
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 10 (2) , 124-129
Antipsychotic Medication Nonadherence: Risk Factors and Remedies
- 1 January 2012
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 10 (2) , 124-129
Antipsychotic Medication Nonadherence: Risk Factors and Remedies
- 30 November 2010
- Published by Elsevier in Medical Clinics of North America
- Vol. 94 (6) , 1217-1227
An Approach to Symptoms at the Interface of Medicine and Psychiatry: Pain, Insomnia, Weight Loss and Anorexia, Fatigue and Forgetfulness, and Sexual Dysfunction
- 30 November 2010
- Published by Elsevier in Medical Clinics of North America
- Vol. 94 (6) , 1217-1227
An Approach to Symptoms at the Interface of Medicine and Psychiatry: Pain, Insomnia, Weight Loss and Anorexia, Fatigue and Forgetfulness, and Sexual Dysfunction
- 1 November 2010
- Published by Elsevier in Psychosomatics
- Vol. 51 (6) , 480-488
Psychiatric Treatment of Persons With HIV/AIDS: An HIV-Psychiatry Consensus Survey of Current Practices
- 1 November 2010
- Published by Elsevier in Psychosomatics
- Vol. 51 (6) , 480-488
Psychiatric Treatment of Persons With HIV/AIDS: An HIV-Psychiatry Consensus Survey of Current Practices
- 1 November 2010
- Published by Elsevier in Psychosomatics
- Vol. 51 (6) , 453-457
Morgellons Disease, or Antipsychotic-Responsive Delusional Parasitosis, in an HIV Patient: Beliefs in The Age of the Internet
- 1 November 2010
- Published by Elsevier in Psychosomatics
- Vol. 51 (6) , 453-457
Morgellons Disease, or Antipsychotic-Responsive Delusional Parasitosis, in an HIV Patient: Beliefs in The Age of the Internet